<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Here, we describe a procedure and first-in-man clinical effects of adoptive transfer of ex vivo expanded CD4+CD25+CD127- T regulatory cells (Tregs) in the treatment of <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft versus host disease</z:e> (GvHD) </plain></SENT>
<SENT sid="1" pm="."><plain>The cells were sorted from buffy coats taken from two family donors, expanded ex vivo and transferred to respective recipients who suffered from either <z:hpo ids='HP_0011009'>acute</z:hpo> or <z:hpo ids='HP_0011010'>chronic</z:hpo> GvHD </plain></SENT>
<SENT sid="2" pm="."><plain>The therapy allowed for significant alleviation of the symptoms and reduction of pharmacologic immunosuppression in the case of <z:hpo ids='HP_0011010'>chronic</z:hpo> GvHD, while in the case of grade IV <z:hpo ids='HP_0011009'>acute</z:hpo> GvHD it only transiently improved the condition, for the longest time within <z:hpo ids='HP_0000001'>all</z:hpo> <z:chebi fb="1" ids="35705">immunosuppressants</z:chebi> used nonetheless </plain></SENT>
</text></document>